Camber Spine to conduct pain study following sacroiliac joint fusion with Prolix


us-fda-clears-camber-spines-enza-alif-deviceCamber Spine has partnered with Joseph DiCicco of Orthopedic Trauma Associates of Southwestern Ohio (Dayton, USA) to conduct a postoperative pain study on patients receiving the Prolix implant.

Patients in the study have undergone pain management therapy for sacroiliac pain over an extended period of time and have now opted for surgical treatment of the sacroiliac joint. The study will compare patient pain scores pre- and postoperatively.

Joseph DiCicco, a trauma consultant and product designer, has been involved in the development of multiple trauma and fracture-care devices over the last several years.

“As the first bone graft delivery system to compliment the ‘old school screws only’ fix of the past, Prolix has revolutionised this difficult diagnosis. This percutaneous procedure has been well received by my patients.”

“A perfect sacroiliac surgery candidate is one who had excellent initial relief from sacroiliac fluoroscopic injection but who slowly, over time, no longer experienced such relief from injection therapy. When I suggest a percutaneous, outpatient surgery to correct a commonly debilitating diagnosis, it often brings tears to my patients’ eyes. Just the option to get long-term relief is a new hope for many of them. I am very pleased with the results so far and will continue to offer this as a permanent fix for my patients.”

The Prolix system is designed to offer a true fusion of the joint through a direct visualisation, minimally invasive approach. The system is used to treat degenerative sacroiliitis and sacroiliac joint disruptions in skeletally mature patients. Prolix is a two-step minimally invasive procedure, which consists of the implantation of a custom machined allograft implant through direct visualisation and a supplemental “lateral fixation of the sacroiliac joint” using supplemental bone screws.